Literature DB >> 10089335

Crystallization and preliminary x-ray analysis of the catalytic subunit of the ATP-dependent arsenite pump encoded by the Escherichia coli plasmid R773.

T Zhou1, B P Rosen, D L Gatti.   

Abstract

The arsenical resistance (ars) operon of the Escherichia coli plasmid R773 encodes a system for the active extrusion from cells of the toxic oxyanions arsenite (AsIIIO2-) and antimonite (SbIIIO2-) via an ATP-driven pump. The arsA and arsB genes of the operon encode the catalytic subunit (ATPase) and the membrane subunit of the pump, respectively. The arsC gene codes for a reductase that converts arsenate (AsVO43-) to arsenite, thus extending bacterial resistance to the pentavalent state of arsenic. Crystals diffracting beyond 2.0 A were obtained for the catalytic subunit of the pump (ArsA). These crystals belong to space group I222, with unit-cell parameters a approximately 73, b approximately 76, c approximately 223 A. A single molecule of ArsA, composed of two homologous halves, occupies the asymmetric unit of the I222 crystals with a predicted solvent content of 46%. Self-rotation function analysis suggests, however, that ArsA adopts a molecular packing corresponding to point group 422. One possible explanation of this result is that the two homologous halves of ArsA are related by a twofold axis of local symmetry and that the two halves of a 'pseudo'-tetramer are related by a crystallographic twofold axis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10089335     DOI: 10.1107/s0907444999000256

Source DB:  PubMed          Journal:  Acta Crystallogr D Biol Crystallogr        ISSN: 0907-4449


  2 in total

1.  The 1.4 A crystal structure of the ArsD arsenic metallochaperone provides insights into its interaction with the ArsA ATPase.

Authors:  Jun Ye; A Abdul Ajees; Jianbo Yang; Barry P Rosen
Journal:  Biochemistry       Date:  2010-06-29       Impact factor: 3.162

2.  Structure of the ArsA ATPase: the catalytic subunit of a heavy metal resistance pump.

Authors:  T Zhou; S Radaev; B P Rosen; D L Gatti
Journal:  EMBO J       Date:  2000-09-01       Impact factor: 11.598

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.